Thymosin Alpha-1 (TA1 / Thymalfasin)

Published · Researched 2026-09-21

Overview

Thymosin Alpha-1 (Tα1) is a 28-amino-acid peptide originally isolated from thymosin fraction 5 of calf thymus (Goldstein, 1977). The synthetic version is called thymalfasin and is sold as the pharmaceutical Zadaxin. It is an immunomodulator — it regulates rather than simply stimulates immunity — acting via Toll-like receptors 2/9, dendritic cells, T-cell maturation, NK-cell activity, and cytokine signaling. In 2026 it is both a long-approved drug in much of the world and one of the most-discussed "immune peptides" in the biohacking/gray-market peptide community, commonly sold as 10 mg lyophilized research vials.

Social standing

• Instagram (highest volume): Peptide-educator reels dominate. Standouts observed Sept 2026: @drtrevorbachmeyer (2.1M followers, Dec 2025 — 3K likes, 3.7K comments) with an impassioned "NF-kB God Switch" monologue framing TA1 as immune modulation for weak immune states (cancer, chronic infection) vs. calming hyperactive/autoimmune states; @mikesheffer_ (56K, IFBB Pro/"Peptide & Longevity Guru", June–July 2026) recommending TA1 first for autoimmune issues, calling it "one of the safest peptides"; a FITSCRIPT educator (July 2026, 650 likes/180 comments) presenting vials on camera, stressing TA1 "regulates rather than overstimulates"; @dprohealth_ (David Prochaska, Sept 2026) keeping TA-1 on hand for fall/winter "immune communication" support; Dr. Diego Allende, DO (Sept 2026) — "THE IMMUNE PEPTIDE EVERYONE'S TALKING ABOUT... APPROVED IN 35+ COUNTRIES... BUT NOT YET IN THE U.S."; a women's-health educator (Sept 2026) citing its 1977 discovery and 35+ country approvals plus Nature papers on thymus health and mortality.
• Viral/controversy moments: A July 2026 reel (23K likes, 670 comments) with on-screen text "THESE 4 PEPTIDES ARE CAUSING CANCER?!" named retatrutide, thymosin alpha-1, thymulin, and epitalon — the creator then reversed himself, asserting they have anti-cancer evidence; comment debate followed. A May 2026 creator cited human oncology data (1995: 56 patients, +12.6 months survival; 2010: 488 stage-IV melanoma patients, improved chemo response; 2016: 146 vs 412 HCC patients post-hepatectomy, reduced recurrence) — claims summarized from video, individual study verification UNVERIFIED.
• Threads: Peptide-community threads discuss TA1 as the "immune regulator" staple of mold/autoimmune protocols; a Sept 2026 KPV thread's commenters also referenced TA1 stacking. Valerie Orsoni (verified biohacker) has discussed TA1-class immune protocols.
• Facebook Groups: TA1 appears in peptide group recommendation threads as the go-to immune peptide for frequent illness/autoimmune-adjacent complaints; group consensus positions it as the "safest" immune peptide. Specific group names/links: observed via social.search across peptide groups — "Peptides - information. Education. and sharing" (facebook.com/groups/1538514733528689) and "Peptide Community 101" (facebook.com/groups/1031179420584990) are the accessible groups found; TA1-specific threads within them were not individually captured — group-level depth UNVERIFIED.
• Recurring praise: "regulates instead of overstimulating"; decades of human data vs. newer peptides; fewer colds/flu ("knocked out my cold symptoms in record time" — @breedlove_22, 130K verified, Aug 2026, crediting LL-37 + TA1, personal anecdote, UNVERIFIED); autoimmune calming narratives.
• Recurring complaints/failure modes: price (pharma-grade Zadaxin is expensive); confusion between pharma Zadaxin and gray-market vials; overstimulation anxiety in Hashimoto's/autoimmune users (debated — educators claim it modulates rather than stimulates); injection-site reactions.
• Representative quotes (attributed): "one of the safest peptides" — @mikesheffer_, Instagram reel, June 2026 (autoimmune context); "APPROVED IN 35+ COUNTRIES... BUT NOT YET IN THE U.S." — Dr. Diego Allende, DO, Instagram reel, Sept 2026; "These two peptides knocked out my cold symptoms in record time" — @breedlove_22, Instagram, Aug 2026 (LL-37 + TA1 anecdote, UNVERIFIED).

Social validation

Tier 1 — strong independent signal across Instagram (multiple large educator accounts, viral reels with thousands of comments), Threads (peptide-community discussion), and Facebook peptide groups (recommendation-thread staple). Named sources: @drtrevorbachmeyer (IG, 2.1M), @mikesheffer_ (IG, 56K), Dr. Diego Allende DO (IG), @dprohealth_ (IG), FITSCRIPT educator (IG), "Peptides - information. Education. and sharing" FB group, "Peptide Community 101" FB group. What each proves: IG proves broad enthusiast awareness + educator-driven narrative; Threads proves peer-to-peer protocol discussion; FB groups prove newcomer-recommendation consensus. Caveat: much IG content is educator-as-vendor funnel content — treat as Tier 1 for awareness, Tier 2 for unbiased owner consensus.

Key specs table

Pricing

• Pharma (Zadaxin 1.6 mg): priced as prescription drug where approved (e.g. China); exact 2026 price UNVERIFIED.
• Gray-market street (observed 2026-09-20): Cosmic Peptides (US) — 5 mg $42.99 (sale), 10 mg $69.99 (out of stock at crawl); Peptide Hubs — 10 mg $95.00; Infinity Lab (Canada) — 10 mg $98.99 CAD; Regen Peptides (UK) — 10 mg £35.00; Bio Peptides UK — 10 mg £46.00; OZZ Peptides (Australia) — 10 mg $195.95 AUD. Typical US range ~$43–99 per 5–10 mg vial.
• Facebook Marketplace: no used TA1 listings observed — say so plainly (none found).

What's included / what's needed

Vial: lyophilized TA1 powder (2/5/10 mg) in sealed 3–5 mL vial. Needed: bacteriostatic water for reconstitution, insulin syringes, alcohol swabs (standard peptide kit; vendors often bundle). Zadaxin pharma ships as 1.6 mg lyophilized + 1 mL diluent.

Support reality

Gray-market vendors (Umbrella Labs, Cosmic Peptides, etc.) publish COAs and claim third-party LC-MS testing; community trust varies by vendor and batch. Counterfeit/mislabeled vials are a recurring community concern; buyers are advised to check third-party COAs (e.g. PeptidePub price/COA comparisons). No warranty in the consumer sense — research-chemical terms disclaim human use. Pharma Zadaxin has normal drug support channels where approved.

Community verdict

Thymosin Alpha-1 is the immune category's consensus "safest, most-studied" pick, with genuine pharma history (35+ countries) that no other peptide in this track can claim. The community treats it as the immune regulator for frequent illness and autoimmune-adjacent protocols, though the Hashimoto's/overstimulation debate is unresolved and most dosing talk is anecdotal. Gray-market buyers trade the pharma pedigree for cheap vials with uneven quality assurance.

Regulatory & safety status

Pharma thymalfasin (Zadaxin) is an approved drug in 35+ countries (notably China, for chronic hepatitis B, 1.6 mg twice weekly) — it is NOT FDA-approved in the United States and has no EMA approval. Gray-market "research" TA1 vials are research chemicals not for human use; vendors explicitly disclaim human consumption. Safety signals (observed): injection-site redness/swelling; community debate over immune overstimulation in autoimmune disease (Hashimoto's) — educators claim modulation, some users report flares (anecdotal, UNVERIFIED); pharma label lists allergic reactions as the main adverse event. Do not confuse vendor COAs with drug approval.

Image view breakdown

6/8 views obtained, all real vendor product photos (Umbrella Labs TA1 vial listings, downloaded 2026-09-20, converted to JPEG):

• hero: thymosin-alpha-1-hero.jpg (10 mg vial, front)
• side: thymosin-alpha-1-side.jpg (10 mg vial, alternate angle)
• rear: thymosin-alpha-1-rear.jpg (10 mg vial, third angle — true rear-label view unavailable, noted)
• top: thymosin-alpha-1-top.jpg (5 mg variant, vial + box angled — variant noted, primary is 10 mg)
• detail: thymosin-alpha-1-detail.jpg (2 mg variant label closeup — variant noted)
• box: thymosin-alpha-1-box.jpg (10 mg vial + retail box) Missing views: inuse (no real owner in-use photo found), scale (no scale-reference photo found).

Not medical advice. This is a research summary of publicly discussed information, not a recommendation to use any substance.

Named sources

• @drtrevorbachmeyer (IG, 2.1M) — IG proves broad enthusiast awareness + educator-driven narrative; Threads proves peer-to-peer protocol discussion; FB groups prove newcomer-recommendation consensus. Caveat: much IG content is educator-as-vendor funnel content — treat as Tier 1 for awareness, Tier 2 for unbiased owner consensus.
• @mikesheffer_ (IG, 56K) — IG proves broad enthusiast awareness + educator-driven narrative; Threads proves peer-to-peer protocol discussion; FB groups prove newcomer-recommendation consensus. Caveat: much IG content is educator-as-vendor funnel content — treat as Tier 1 for awareness, Tier 2 for unbiased owner consensus.
• Dr. Diego Allende DO (IG) — IG proves broad enthusiast awareness + educator-driven narrative; Threads proves peer-to-peer protocol discussion; FB groups prove newcomer-recommendation consensus. Caveat: much IG content is educator-as-vendor funnel content — treat as Tier 1 for awareness, Tier 2 for unbiased owner consensus.
• @dprohealth_ (IG) — IG proves broad enthusiast awareness + educator-driven narrative; Threads proves peer-to-peer protocol discussion; FB groups prove newcomer-recommendation consensus. Caveat: much IG content is educator-as-vendor funnel content — treat as Tier 1 for awareness, Tier 2 for unbiased owner consensus.
• FITSCRIPT educator (IG) — IG proves broad enthusiast awareness + educator-driven narrative
• "Peptides - information. Education. and sharing" FB group — IG proves broad enthusiast awareness + educator-driven narrative; Threads proves peer-to-peer protocol discussion; FB groups prove newcomer-recommendation consensus. Caveat: much IG content is educator-as-vendor funnel content — treat as Tier 1 for awareness, Tier 2 for unbiased owner consensus.
• "Peptide Community 101" FB group — IG proves broad enthusiast awareness + educator-driven narrative; Threads proves peer-to-peer protocol discussion; FB groups prove newcomer-recommendation consensus. Caveat: much IG content is educator-as-vendor funnel content — treat as Tier 1 for awareness, Tier 2 for unbiased owner consensus.
• @breedlove_22 — newer peptides; fewer colds/flu ("knocked out my cold symptoms in record time" — @breedlove_22, 130K verified, Aug 2026, crediting LL-37 + TA1, personal anecdote, UNVERIFIED); autoimmune calming narratives. (Aug 2026)
• social.search — Specific group names/links: observed via social.search across peptide groups — "Peptides - information.
• Instagram (highest volume) — Peptide-educator reels dominate. (Sept 2026)
• Threads — Peptide-community threads discuss TA1 as the "immune regulator" staple of mold/autoimmune protocols; a Sept 2026 KPV thread's commenters also referenced TA1 stacking. (Sept 2026)
• Facebook Groups — TA1 appears in peptide group recommendation threads as the go-to immune peptide for frequent illness/autoimmune-adjacent complaints; group consensus positions it as the "safest" immune peptide.

Source URLs were not recorded for these references.